Association of BMI with overall survival in patients with mCRC who received chemotherapy versus EGFR and VEGF-targeted therapies

Although a raised body mass index (BMI) is associated with increased risk of colorectal cancer (CRC) and recurrence after adjuvant treatment, data in the metastatic setting is limited. We compared overall survival (OS) across BMI groups for metastatic CRC, and specifically examined the effect of BMI...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Gargi S, Ullah, Shahid, Beeke, Carol, Hakendorf, Paul, Padbury, Robert, Price, Timothy J, Karapetis, Christos S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618617/
https://www.ncbi.nlm.nih.gov/pubmed/26211512
http://dx.doi.org/10.1002/cam4.490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618617/
https://www.ncbi.nlm.nih.gov/pubmed/26211512
http://dx.doi.org/10.1002/cam4.490

Ejemplares similares